Watson PA, Arora VK, Sawyers CL (2015) Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer 15(12):701–711
Article PubMed PubMed Central CAS Google Scholar
Abida W, Cyrta J, Heller G et al (2019) Genomic correlates of clinical outcome in advanced prostate cancer. PNAS 116(23):11428–11436
Article PubMed PubMed Central CAS Google Scholar
Zong WX, Rabinowitz JD, White E (2016) Mitochondria and cancer. Mol Cell 61(5):667–676
Article PubMed PubMed Central CAS Google Scholar
Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12(10):685–698
Article PubMed PubMed Central CAS Google Scholar
Chan DC (2020) Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol 15:235–259
Article PubMed CAS Google Scholar
Archer SL (2013) Mitochondrial dynamics—mitochondrial fission and fusion in human diseases. N Engl J Med 369(23):2236–2251
Article PubMed CAS Google Scholar
Youle RJ, van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337(6098):1062–1065
Article PubMed PubMed Central CAS Google Scholar
Serasinghe MN, Chipuk JE (2017) Mitochondrial fission in human diseases. Handb Exp Pharmacol 240:159–188
Article PubMed PubMed Central CAS Google Scholar
Kashatus DF (2018) The regulation of mitochondrial morphology: Complexities and opportunities. Trends Cell Biol 28(9):735–746
Rehman J (2016) Targeting mitochondrial dynamics to treat cancer. J Clin Invest 126(1):15–17
de Bono JS, Mateo J, Fizazi K et al (2020) Olaparib for metastatic castration-resistant prostate cancer. NEJM 382(22):2091–2102
Lord CJ, Ashworth A (2017) PARP inhibitors: synthetic lethality in the clinic. Science 355(6330):1152–1158
Article PubMed PubMed Central CAS Google Scholar
Bai P (2015) Biology of poly(ADP-ribose) polymerases: the factotums of cell maintenance. Mol Cell 58(6):947–958
Article PubMed CAS Google Scholar
Bock FJ, Tait SWG (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21(2):85–100
Article PubMed CAS Google Scholar
Gogola E, Rottenberg S, Jonkers J (2019) Resistance to PARP inhibitors: lessons from preclinical models of BRCA-associated cancer. Annu Rev Cancer Biol 3:235–254
Fukumoto K et al (2016) Mitochondrial fragmentation in PARP-inhibitor treated ovarian cancer cells. Oncotarget 7(36):58840–58853
Mendez LC et al (2020) Targeting mitochondrial dynamics and metabolism to overcome therapeutic resistance in prostate cancer. Front Oncol 10:196
Freshney RI (2010) Culture of animal cells: A manual of basic technique and specialized applications (6th ed.). Wiley-Blackwell.
Sumi M, Kiuchi K, Ishikawa T et al (1992) The newly synthesized selective CaMKII inhibitor KN-93 reduces dopamine content in PC12h cells. Neurosci Lett 139(1):89–92
Tominaga H, Ishiyama M, Ohseto F et al (1999) A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun 36(2):47–50
Graham JM (2001) Isolation of mitochondria from tissues and cells by differential centrifugation. Curr Protoc Cell Biol, Chapter 3, Unit 3.3.
Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76–85
Article PubMed CAS Google Scholar
Mahmood T, Yang PC (2012) Western blot: Technique, theory, and troubleshooting. North Am J Med Sci 4(9):429–434
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156–159
Article PubMed CAS Google Scholar
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2⁻ΔΔCT method. Methods 25(4):402–408
Article PubMed CAS Google Scholar
Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119(3):493–501. https://doi.org/10.1083/jcb.119.3.493
Article PubMed CAS Google Scholar
Nicholson DW, Ali A, Thornberry NA et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376(6535):37–43
Article PubMed CAS Google Scholar
Mateo J, Porta N, Bianchini D et al (2015) DNA-repair defects and olaparib in metastatic prostate cancer. NEJM 373(18):1697–1708. https://doi.org/10.1056/NEJMoa1506859
Article PubMed CAS Google Scholar
Wang Y, Zhu G, Ma J et al (2019) Rucaparib induces apoptosis and autophagy in non-small cell lung cancer cells via the mitochondrial pathway. Mol Med Rep 20(6):4827–4836. https://doi.org/10.3892/mmr.2019.10766
Yuan H, Meng Q, Liao M et al (2018) Rucaparib induces apoptosis and cell cycle arrest in pancreatic cancer cells via mitochondrial dysfunction. J Cell Biochem 119(4):3483–3494. https://doi.org/10.1002/jcb.26505
Pilié PG, Tang C, Mills GB, Yap TA (2019) State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol 16:81–104. https://doi.org/10.1038/s41571-018-0114-z
Article PubMed PubMed Central CAS Google Scholar
Patel MR, Jiang F, Nakagawa H et al (2020) Mitochondrial dysfunction is a critical mediator of Rucaparib-induced cytotoxicity in ovarian cancer cells. Cancer Lett 482:52–63. https://doi.org/10.1016/j.canlet.2020.05.013
Spinelli JB, Haigis MC (2018) The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol 20(7):745–754. https://doi.org/10.1038/s41556-018-0124-1
Article PubMed PubMed Central CAS Google Scholar
Anderson CM, Stoker S, D’Amato NC et al (2020) Targeting mitochondrial metabolism to overcome resistance to antiandrogen therapy in prostate cancer. Nat Commun 11(1):507. https://doi.org/10.1038/s41467-019-14142-8
Chang CR, Blackstone C (2010) Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann NY Acad Sci 1201:34–39. https://doi.org/10.1111/j.1749-6632.2010.05618.x
Article PubMed CAS Google Scholar
Rehman J, Zhang HJ, Toth PT et al (2012) Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J 26(5):2175–2186. https://doi.org/10.1096/fj.11-197506
Comments (0)